Supporting clinical decision-making during the SARS-CoV-2 pandemic through a global research commitment: The TERAVOLT experience Editorial
| Authors: | Trama, A.; Proto, C.; Whisenant, J. G.; Torri, V.; Cortellini, A.; Michielin, O.; Barlesi, F.; Dingemans, A. M. C.; Van Meerbeeck, J.; Pancaldi, V.; Mazieres, J.; Soo, R. A.; Leighl, N. B.; Peters, S.; Wakelee, H.; Horn, L.; Hellmann, M.; Wong, S. K.; Garassino, M. C.; Baena, J. |
| Title: | Supporting clinical decision-making during the SARS-CoV-2 pandemic through a global research commitment: The TERAVOLT experience |
| Abstract: | To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic. © 2020 Elsevier Inc. |
| Journal Title: | Cancer Cell |
| Volume: | 38 |
| Issue: | 5 |
| ISSN: | 1535-6108 |
| Publisher: | Cell Press |
| Date Published: | 2020-11-09 |
| Start Page: | 602 |
| End Page: | 604 |
| Language: | English |
| DOI: | 10.1016/j.ccell.2020.10.002 |
| PUBMED: | 33091381 |
| PROVIDER: | scopus |
| PMCID: | PMC7534826 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 December 2020 -- Source: Scopus |
